Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $49.4 million.

  • Maravai Lifesciences Holdings' Other Non-Current Assets fell 1891.03% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year decrease of 1891.03%. This contributed to the annual value of $59.8 million for FY2024, which is 2297.42% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Other Non-Current Assets is $49.4 million, which was down 1891.03% from $52.0 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Non-Current Assets registered a high of $127.0 million during Q1 2023, and its lowest value of $4.1 million during Q3 2021.
  • Its 5-year average for Other Non-Current Assets is $69.9 million, with a median of $64.2 million in 2022.
  • Data for Maravai Lifesciences Holdings' Other Non-Current Assets shows a peak YoY increase of 202856.79% (in 2022) and a maximum YoY decrease of 4208.06% (in 2022) over the last 5 years.
  • Maravai Lifesciences Holdings' Other Non-Current Assets (Quarter) stood at $53.5 million in 2021, then skyrocketed by 116.25% to $115.6 million in 2022, then crashed by 32.85% to $77.6 million in 2023, then fell by 22.97% to $59.8 million in 2024, then fell by 17.38% to $49.4 million in 2025.
  • Its Other Non-Current Assets stands at $49.4 million for Q3 2025, versus $52.0 million for Q2 2025 and $57.6 million for Q1 2025.